Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

124

...

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AB05	CIMZIA	BioTech	Certolizumab - 200mg/ml	200mg/ml	Injectable solution	72,984,763 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 500IU	500IU	Injectable powder for solution+solvent	1,312,563 L.L
L04AB06	SIMPONI	BioTech	Golimumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	83,360,986 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 1000IU	1000IU	Injectable powder for solution+solvent	2,832,997 L.L
L04AB06	SIMPONI	BioTech	Golimumab - 100mg/1ml	100mg/1ml	Injectable solution	83,360,986 L.L
B02BD04	REFIXIA	BioTech	Nonacog beta pegol (factor IX) - 2000IU	2000IU	Injectable powder for solution+solvent	5,665,526 L.L
L04AC02	SIMULECT	BioTech	Basiliximab - 20mg	20mg	Injectable powder + solvent	126,811,740 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	231,551,251 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	5,834,030 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	231,551,251 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	1,046,598 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	222,845,264 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 162mg/0.9ml	162mg/0.9ml	Injectable solution	79,959,812 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	1,689,135 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 200mg/10ml	200mg/10ml	Injectable concentrated solution	25,362,219 L.L
B02BD08	ARYOSEVEN RT	BioTech	Eptacog alfa - 1mg	1mg	Injectable powder for solution+diluent	16,902,713 L.L
L01CD01	ABRAXANE	BioTech	Paclitaxel Albumin- bound - 5mg/ml	5mg/ml	Injectable powder for suspension	17,850,751 L.L
L04AC07	ACTEMRA	BioTech	Tocilizumab - 400mg/20ml	400mg/20ml	Injectable concentrated solution	47,925,322 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	922,866 L.L
N02CD01	AIMOVIG	BioTech	Erenumab - 70mg/ml	70mg/ml	Injectable solution	14,782,826 L.L
L04AC10	COSENTYX	BioTech	Secukinumab - 150mg/ml	150mg/ml	Injectable solution	70,463,329 L.L
A10AB01	ACTRAPID	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable solution	1,440,378 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 5mg	5mg (250KIU)	Injectable powder for solution+diluent	4,222,855 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 600mg, Trastuzumab - 600mg		Injectable solution	5,348,082 L.L
N02CD01	AIMOVIG	BioTech	Erenumab - 140mg/ml	140mg/ml	Injectable solution	14,782,826 L.L
L04AC10	COSENTYX	BioTech	Secukinumab - 150mg/ml	150mg/ml	Injectable solution	58,729,511 L.L
A10AB01	ACTRAPID	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable solution	752,552 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	800,628 L.L
L01XY02	PHESGO	BioTech	Pertuzumab - 1200mg, Trastuzumab - 600mg		Injectable solution	9,700,693 L.L
N02CD02	EMGALITY	BioTech	Galcanezumab - 120mg/ml	120mg/ml	Injectable suspension	6,094,498 L.L

...

124

...